APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma Grade Glycine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharma Grade Glycine Market Outlook and Growth Opportunities 2026

19 December 2025193 pages

Choose your research edition.

Industry ResearchPharma Grade Glycine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma Grade Glycine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Pharma Grade Glycine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma Grade Glycine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma Grade Glycine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pharma Grade Glycine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharma Grade Glycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharma Grade Glycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharma Grade Glycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharma Grade Glycine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharma Grade Glycine market include Shijiazhuang Donghua Jinlong Chemical, Linxi Hongtai, Hubei Xingfa Chemicals Group, Zhenxing Chemical, Hebei Donghua Jiheng Chemical, Hebei Donghuajian Chemicals, Showa Denko KK, Paras Intermediates Private Limited and Newtrend Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharma Grade Glycine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharma Grade Glycine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharma Grade Glycine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharma Grade Glycine market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharma Grade Glycine Segment by Company

Shijiazhuang Donghua Jinlong Chemical

Linxi Hongtai

Hubei Xingfa Chemicals Group

Zhenxing Chemical

Hebei Donghua Jiheng Chemical

Hebei Donghuajian Chemicals

Showa Denko KK

Paras Intermediates Private Limited

Newtrend Group

GEO Specialty Chemicals

Evonik

Chattem Chemicals

Ajinomoto

Pharma Grade Glycine Segment by Type

Chloroacetic Acid Amide Solution

Biosynthesis

Pharma Grade Glycine Segment by Application

Hospitals

Labs

Pharma Grade Glycine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pharma Grade Glycine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharma Grade Glycine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharma Grade Glycine significant trends, drivers, influence factors in global and regions.

6. To analyze Pharma Grade Glycine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Grade Glycine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma Grade Glycine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Grade Glycine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharma Grade Glycine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharma Grade Glycine industry.

Chapter 3: Detailed analysis of Pharma Grade Glycine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharma Grade Glycine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharma Grade Glycine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharma Grade Glycine Industry Trends Table 2. Pharma Grade Glycine Industry Drivers Table 3. Pharma Grade Glycine Industry Opportunities and Challenges Table 4. Pharma Grade Glycine Industry Restraints Table 5. Global Pharma Grade Glycine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharma Grade Glycine Revenue Share by Company (2021-2026) Table 7. Global Pharma Grade Glycine Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Pharma Grade Glycine Sales Volume Share by Company (2021-2026) Table 9. Global Pharma Grade Glycine Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Pharma Grade Glycine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharma Grade Glycine Key Company Manufacturing Base & Headquarters Table 12. Global Pharma Grade Glycine Company, Product Type & Application Table 13. Global Pharma Grade Glycine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharma Grade Glycine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Chloroacetic Acid Amide Solution Table 18. Significant Companies of Biosynthesis Table 19. Global Pharma Grade Glycine Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Pharma Grade Glycine Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Pharma Grade Glycine Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Pharma Grade Glycine Sales Volume Share by Type (2021-2026) Table 23. Global Pharma Grade Glycine Sales Volume Share by Type (2027-2032) Table 24. Global Pharma Grade Glycine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pharma Grade Glycine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pharma Grade Glycine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pharma Grade Glycine Sales Value Share by Type (2021-2026) Table 28. Global Pharma Grade Glycine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Labs Table 31. Global Pharma Grade Glycine Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Pharma Grade Glycine Sales Volume by Application (2021-2026) & (Tons) Table 33. Global Pharma Grade Glycine Sales Volume by Application (2027-2032) & (Tons) Table 34. Global Pharma Grade Glycine Sales Volume Share by Application (2021-2026) Table 35. Global Pharma Grade Glycine Sales Volume Share by Application (2027-2032) Table 36. Global Pharma Grade Glycine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pharma Grade Glycine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Pharma Grade Glycine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Pharma Grade Glycine Sales Value Share by Application (2021-2026) Table 40. Global Pharma Grade Glycine Sales Value Share by Application (2027-2032) Table 41. Global Pharma Grade Glycine Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Pharma Grade Glycine Sales by Region (2021-2026) & (Tons) Table 43. Global Pharma Grade Glycine Sales Market Share by Region (2021-2026) Table 44. Global Pharma Grade Glycine Sales by Region (2027-2032) & (Tons) Table 45. Global Pharma Grade Glycine Sales Market Share by Region (2027-2032) Table 46. Global Pharma Grade Glycine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pharma Grade Glycine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Pharma Grade Glycine Sales Value Share by Region (2021-2026) Table 49. Global Pharma Grade Glycine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Pharma Grade Glycine Sales Value Share by Region (2027-2032) Table 51. Global Pharma Grade Glycine Market Average Price (US$/Ton) by Region (2021-2026) Table 52. Global Pharma Grade Glycine Market Average Price (US$/Ton) by Region (2027-2032) Table 53. Global Pharma Grade Glycine Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Global Pharma Grade Glycine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Pharma Grade Glycine Sales by Country (2021-2026) & (Tons) Table 56. Global Pharma Grade Glycine Sales Market Share by Country (2021-2026) Table 57. Global Pharma Grade Glycine Sales by Country (2027-2032) & (Tons) Table 58. Global Pharma Grade Glycine Sales Market Share by Country (2027-2032) Table 59. Global Pharma Grade Glycine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Pharma Grade Glycine Sales Value Market Share by Country (2021-2026) Table 61. Global Pharma Grade Glycine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Pharma Grade Glycine Sales Value Market Share by Country (2027-2032) Table 63. Shijiazhuang Donghua Jinlong Chemical Company Information Table 64. Shijiazhuang Donghua Jinlong Chemical Business Overview Table 65. Shijiazhuang Donghua Jinlong Chemical Pharma Grade Glycine Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Shijiazhuang Donghua Jinlong Chemical Pharma Grade Glycine Product Portfolio Table 67. Shijiazhuang Donghua Jinlong Chemical Recent Development Table 68. Linxi Hongtai Company Information Table 69. Linxi Hongtai Business Overview Table 70. Linxi Hongtai Pharma Grade Glycine Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Linxi Hongtai Pharma Grade Glycine Product Portfolio Table 72. Linxi Hongtai Recent Development Table 73. Hubei Xingfa Chemicals Group Company Information Table 74. Hubei Xingfa Chemicals Group Business Overview Table 75. Hubei Xingfa Chemicals Group Pharma Grade Glycine Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Hubei Xingfa Chemicals Group Pharma Grade Glycine Product Portfolio Table 77. Hubei Xingfa Chemicals Group Recent Development Table 78. Zhenxing Chemical Company Information Table 79. Zhenxing Chemical Business Overview Table 80. Zhenxing Chemical Pharma Grade Glycine Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Zhenxing Chemical Pharma Grade Glycine Product Portfolio Table 82. Zhenxing Chemical Recent Development Table 83. Hebei Donghua Jiheng Chemical Company Information Table 84. Hebei Donghua Jiheng Chemical Business Overview Table 85. Hebei Donghua Jiheng Chemical Pharma Grade Glycine Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Hebei Donghua Jiheng Chemical Pharma Grade Glycine Product Portfolio Table 87. Hebei Donghua Jiheng Chemical Recent Development Table 88. Hebei Donghuajian Chemicals Company Information Table 89. Hebei Donghuajian Chemicals Business Overview Table 90. Hebei Donghuajian Chemicals Pharma Grade Glycine Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Hebei Donghuajian Chemicals Pharma Grade Glycine Product Portfolio Table 92. Hebei Donghuajian Chemicals Recent Development Table 93. Showa Denko KK Company Information Table 94. Showa Denko KK Business Overview Table 95. Showa Denko KK Pharma Grade Glycine Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Showa Denko KK Pharma Grade Glycine Product Portfolio Table 97. Showa Denko KK Recent Development Table 98. Paras Intermediates Private Limited Company Information Table 99. Paras Intermediates Private Limited Business Overview Table 100. Paras Intermediates Private Limited Pharma Grade Glycine Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Paras Intermediates Private Limited Pharma Grade Glycine Product Portfolio Table 102. Paras Intermediates Private Limited Recent Development Table 103. Newtrend Group Company Information Table 104. Newtrend Group Business Overview Table 105. Newtrend Group Pharma Grade Glycine Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Newtrend Group Pharma Grade Glycine Product Portfolio Table 107. Newtrend Group Recent Development Table 108. GEO Specialty Chemicals Company Information Table 109. GEO Specialty Chemicals Business Overview Table 110. GEO Specialty Chemicals Pharma Grade Glycine Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. GEO Specialty Chemicals Pharma Grade Glycine Product Portfolio Table 112. GEO Specialty Chemicals Recent Development Table 113. Evonik Company Information Table 114. Evonik Business Overview Table 115. Evonik Pharma Grade Glycine Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Evonik Pharma Grade Glycine Product Portfolio Table 117. Evonik Recent Development Table 118. Chattem Chemicals Company Information Table 119. Chattem Chemicals Business Overview Table 120. Chattem Chemicals Pharma Grade Glycine Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Chattem Chemicals Pharma Grade Glycine Product Portfolio Table 122. Chattem Chemicals Recent Development Table 123. Ajinomoto Company Information Table 124. Ajinomoto Business Overview Table 125. Ajinomoto Pharma Grade Glycine Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Ajinomoto Pharma Grade Glycine Product Portfolio Table 127. Ajinomoto Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Pharma Grade Glycine Distributors List Table 131. Pharma Grade Glycine Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Pharma Grade Glycine Product Image Figure 2. Global Pharma Grade Glycine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma Grade Glycine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharma Grade Glycine Sales (2021-2032) & (Tons) Figure 5. Global Pharma Grade Glycine Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Pharma Grade Glycine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Chloroacetic Acid Amide Solution Image Figure 10. Biosynthesis Image Figure 11. Global Pharma Grade Glycine Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Pharma Grade Glycine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pharma Grade Glycine Sales Volume Share by Type (2021-2032) Figure 14. Global Pharma Grade Glycine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pharma Grade Glycine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pharma Grade Glycine Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Labs Image Figure 19. Global Pharma Grade Glycine Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Pharma Grade Glycine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Pharma Grade Glycine Sales Volume Share by Application (2021-2032) Figure 22. Global Pharma Grade Glycine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pharma Grade Glycine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Pharma Grade Glycine Sales Value Share by Application (2021-2032) Figure 25. Global Pharma Grade Glycine Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 26. Global Pharma Grade Glycine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Pharma Grade Glycine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Pharma Grade Glycine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Pharma Grade Glycine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Pharma Grade Glycine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Pharma Grade Glycine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Pharma Grade Glycine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Pharma Grade Glycine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Pharma Grade Glycine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Pharma Grade Glycine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Pharma Grade Glycine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Pharma Grade Glycine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Pharma Grade Glycine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Pharma Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Pharma Grade Glycine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Pharma Grade Glycine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Chloroacetic Acid Amide Solution
  • Biosynthesis
Applications
  • Hospitals
  • Labs
Companies covered
  • Shijiazhuang Donghua Jinlong Chemical
  • Linxi Hongtai
  • Hubei Xingfa Chemicals Group
  • Zhenxing Chemical
  • Hebei Donghua Jiheng Chemical
  • Hebei Donghuajian Chemicals
  • Showa Denko KK
  • Paras Intermediates Private Limited
  • Newtrend Group
  • GEO Specialty Chemicals
  • Evonik
  • Chattem Chemicals
  • Ajinomoto

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharma Grade Glycine Sales Value (2021-2032)
  4. 1.2.2 Global Pharma Grade Glycine Sales Volume (2021-2032)
  5. 1.2.3 Global Pharma Grade Glycine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharma Grade Glycine Market Dynamics
  1. 2.1 Pharma Grade Glycine Industry Trends
  2. 2.2 Pharma Grade Glycine Industry Drivers
  3. 2.3 Pharma Grade Glycine Industry Opportunities and Challenges
  4. 2.4 Pharma Grade Glycine Industry Restraints
3 Pharma Grade Glycine Market by Company
  1. 3.1 Global Pharma Grade Glycine Company Revenue Ranking in 2025
  2. 3.2 Global Pharma Grade Glycine Revenue by Company (2021-2026)
  3. 3.3 Global Pharma Grade Glycine Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharma Grade Glycine Average Price by Company (2021-2026)
  5. 3.5 Global Pharma Grade Glycine Company Ranking (2024-2026)
  6. 3.6 Global Pharma Grade Glycine Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharma Grade Glycine Company Product Type and Application
  8. 3.8 Global Pharma Grade Glycine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharma Grade Glycine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharma Grade Glycine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharma Grade Glycine Market by Type
  1. 4.1 Pharma Grade Glycine Type Introduction
  2. 4.1.1 Chloroacetic Acid Amide Solution
  3. 4.1.2 Biosynthesis
  4. 4.2 Global Pharma Grade Glycine Sales Volume by Type
  5. 4.2.1 Global Pharma Grade Glycine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharma Grade Glycine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pharma Grade Glycine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pharma Grade Glycine Sales Value by Type
  9. 4.3.1 Global Pharma Grade Glycine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pharma Grade Glycine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pharma Grade Glycine Sales Value Share by Type (2021-2032)
5 Pharma Grade Glycine Market by Application
  1. 5.1 Pharma Grade Glycine Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Labs
  4. 5.2 Global Pharma Grade Glycine Sales Volume by Application
  5. 5.2.1 Global Pharma Grade Glycine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pharma Grade Glycine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Pharma Grade Glycine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Pharma Grade Glycine Sales Value by Application
  9. 5.3.1 Global Pharma Grade Glycine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pharma Grade Glycine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Pharma Grade Glycine Sales Value Share by Application (2021-2032)
6 Pharma Grade Glycine Regional Sales and Value Analysis
  1. 6.1 Global Pharma Grade Glycine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharma Grade Glycine Sales by Region (2021-2032)
  3. 6.2.1 Global Pharma Grade Glycine Sales by Region: 2021-2026
  4. 6.2.2 Global Pharma Grade Glycine Sales by Region (2027-2032)
  5. 6.3 Global Pharma Grade Glycine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharma Grade Glycine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharma Grade Glycine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharma Grade Glycine Sales Value by Region (2027-2032)
  9. 6.5 Global Pharma Grade Glycine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharma Grade Glycine Sales Value (2021-2032)
  12. 6.6.2 North America Pharma Grade Glycine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharma Grade Glycine Sales Value (2021-2032)
  15. 6.7.2 Europe Pharma Grade Glycine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharma Grade Glycine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharma Grade Glycine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharma Grade Glycine Sales Value (2021-2032)
  21. 6.9.2 South America Pharma Grade Glycine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharma Grade Glycine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharma Grade Glycine Sales Value Share by Country, 2025 VS 2032
7 Pharma Grade Glycine Country-level Sales and Value Analysis
  1. 7.1 Global Pharma Grade Glycine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharma Grade Glycine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharma Grade Glycine Sales by Country (2021-2032)
  4. 7.3.1 Global Pharma Grade Glycine Sales by Country (2021-2026)
  5. 7.3.2 Global Pharma Grade Glycine Sales by Country (2027-2032)
  6. 7.4 Global Pharma Grade Glycine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharma Grade Glycine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharma Grade Glycine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharma Grade Glycine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharma Grade Glycine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharma Grade Glycine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shijiazhuang Donghua Jinlong Chemical
  2. 8.1.1 Shijiazhuang Donghua Jinlong Chemical Company Information
  3. 8.1.2 Shijiazhuang Donghua Jinlong Chemical Business Overview
  4. 8.1.3 Shijiazhuang Donghua Jinlong Chemical Pharma Grade Glycine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shijiazhuang Donghua Jinlong Chemical Pharma Grade Glycine Product Portfolio
  6. 8.1.5 Shijiazhuang Donghua Jinlong Chemical Recent Developments
  7. 8.2 Linxi Hongtai
  8. 8.2.1 Linxi Hongtai Company Information
  9. 8.2.2 Linxi Hongtai Business Overview
  10. 8.2.3 Linxi Hongtai Pharma Grade Glycine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Linxi Hongtai Pharma Grade Glycine Product Portfolio
  12. 8.2.5 Linxi Hongtai Recent Developments
  13. 8.3 Hubei Xingfa Chemicals Group
  14. 8.3.1 Hubei Xingfa Chemicals Group Company Information
  15. 8.3.2 Hubei Xingfa Chemicals Group Business Overview
  16. 8.3.3 Hubei Xingfa Chemicals Group Pharma Grade Glycine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hubei Xingfa Chemicals Group Pharma Grade Glycine Product Portfolio
  18. 8.3.5 Hubei Xingfa Chemicals Group Recent Developments
  19. 8.4 Zhenxing Chemical
  20. 8.4.1 Zhenxing Chemical Company Information
  21. 8.4.2 Zhenxing Chemical Business Overview
  22. 8.4.3 Zhenxing Chemical Pharma Grade Glycine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zhenxing Chemical Pharma Grade Glycine Product Portfolio
  24. 8.4.5 Zhenxing Chemical Recent Developments
  25. 8.5 Hebei Donghua Jiheng Chemical
  26. 8.5.1 Hebei Donghua Jiheng Chemical Company Information
  27. 8.5.2 Hebei Donghua Jiheng Chemical Business Overview
  28. 8.5.3 Hebei Donghua Jiheng Chemical Pharma Grade Glycine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hebei Donghua Jiheng Chemical Pharma Grade Glycine Product Portfolio
  30. 8.5.5 Hebei Donghua Jiheng Chemical Recent Developments
  31. 8.6 Hebei Donghuajian Chemicals
  32. 8.6.1 Hebei Donghuajian Chemicals Company Information
  33. 8.6.2 Hebei Donghuajian Chemicals Business Overview
  34. 8.6.3 Hebei Donghuajian Chemicals Pharma Grade Glycine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hebei Donghuajian Chemicals Pharma Grade Glycine Product Portfolio
  36. 8.6.5 Hebei Donghuajian Chemicals Recent Developments
  37. 8.7 Showa Denko KK
  38. 8.7.1 Showa Denko KK Company Information
  39. 8.7.2 Showa Denko KK Business Overview
  40. 8.7.3 Showa Denko KK Pharma Grade Glycine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Showa Denko KK Pharma Grade Glycine Product Portfolio
  42. 8.7.5 Showa Denko KK Recent Developments
  43. 8.8 Paras Intermediates Private Limited
  44. 8.8.1 Paras Intermediates Private Limited Company Information
  45. 8.8.2 Paras Intermediates Private Limited Business Overview
  46. 8.8.3 Paras Intermediates Private Limited Pharma Grade Glycine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Paras Intermediates Private Limited Pharma Grade Glycine Product Portfolio
  48. 8.8.5 Paras Intermediates Private Limited Recent Developments
  49. 8.9 Newtrend Group
  50. 8.9.1 Newtrend Group Company Information
  51. 8.9.2 Newtrend Group Business Overview
  52. 8.9.3 Newtrend Group Pharma Grade Glycine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Newtrend Group Pharma Grade Glycine Product Portfolio
  54. 8.9.5 Newtrend Group Recent Developments
  55. 8.10 GEO Specialty Chemicals
  56. 8.10.1 GEO Specialty Chemicals Company Information
  57. 8.10.2 GEO Specialty Chemicals Business Overview
  58. 8.10.3 GEO Specialty Chemicals Pharma Grade Glycine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 GEO Specialty Chemicals Pharma Grade Glycine Product Portfolio
  60. 8.10.5 GEO Specialty Chemicals Recent Developments
  61. 8.11 Evonik
  62. 8.11.1 Evonik Company Information
  63. 8.11.2 Evonik Business Overview
  64. 8.11.3 Evonik Pharma Grade Glycine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Evonik Pharma Grade Glycine Product Portfolio
  66. 8.11.5 Evonik Recent Developments
  67. 8.12 Chattem Chemicals
  68. 8.12.1 Chattem Chemicals Company Information
  69. 8.12.2 Chattem Chemicals Business Overview
  70. 8.12.3 Chattem Chemicals Pharma Grade Glycine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Chattem Chemicals Pharma Grade Glycine Product Portfolio
  72. 8.12.5 Chattem Chemicals Recent Developments
  73. 8.13 Ajinomoto
  74. 8.13.1 Ajinomoto Company Information
  75. 8.13.2 Ajinomoto Business Overview
  76. 8.13.3 Ajinomoto Pharma Grade Glycine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Ajinomoto Pharma Grade Glycine Product Portfolio
  78. 8.13.5 Ajinomoto Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharma Grade Glycine Value Chain Analysis
  2. 9.1.1 Pharma Grade Glycine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharma Grade Glycine Sales Mode & Process
  6. 9.2 Pharma Grade Glycine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharma Grade Glycine Distributors
  9. 9.2.3 Pharma Grade Glycine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst